Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis (2013)
- Autores:
- Autores USP: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; BUENO, CLEONICE - FM
- Unidade: FM
- DOI: 10.3109/03009742.2012.709272
- Assuntos: DOENÇAS REUMÁTICAS (IMUNOLOGIA); INFLUENZA (IMUNOLOGIA); VACINAS VIRAIS; VACINAÇÃO; ARTRITE REUMATOIDE JUVENIL
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Scandinavian Journal of Rheumatology
- ISSN: 0300-9742
- Volume/Número/Paginação/Ano: v. 42, n. 1, p. 34-40, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AIKAWA, N. E. et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scandinavian Journal of Rheumatology, v. 42, n. 1, p. 34-40, 2013Tradução . . Disponível em: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272. Acesso em: 28 mar. 2024. -
APA
Aikawa, N. E., Campos, L. M. A., Goldenstein-Schainberg, C., Saad, C. G. S., Ribeiro, A. C., Bueno, C., et al. (2013). Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scandinavian Journal of Rheumatology, 42( 1), 34-40. doi:10.3109/03009742.2012.709272 -
NLM
Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, Precioso AR, Timenetsky M do C, Silva CAA, Bonfá E . Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis [Internet]. Scandinavian Journal of Rheumatology. 2013 ; 42( 1): 34-40.[citado 2024 mar. 28 ] Available from: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272 -
Vancouver
Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, Precioso AR, Timenetsky M do C, Silva CAA, Bonfá E . Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis [Internet]. Scandinavian Journal of Rheumatology. 2013 ; 42( 1): 34-40.[citado 2024 mar. 28 ] Available from: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272 - Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?
- Pesquisa de autoanticorpos em pacientes com artrite psoriásica sob terapia anti-TNFα
- Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome
- IV Consenso Brasileiro para pesquisa de autoanticorpos em células HEp-2
- Digital vasculitis in SLE: a minor manifestation of disease activity?
- Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome
- Anticorpo anti-lipoproteína lipase e atividade do LES
- Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
- High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus
- EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement?
Informações sobre o DOI: 10.3109/03009742.2012.709272 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas